EPHA2 and neoplasm: More specifically, tumor-specific T cell response to tumor-associated antigens MAGE-6 and EphA2 is characterized by a predominance of T cells synthesizing IL5 and IL4, together with reduced levels or a complete absence of T lymphocytes expressing IFNγ [6, 7].